Login or Register to view
World leading integrated medicinal cannabis company
Investment Highlights
-
World leading agri-pharma team for cultivation and medicines manufacture
-
Aiming to be Western Australia’s first medicinal cannabis tolling service
-
15 domestic and international distribution channels
Company Overview
-
New vertically integrated medicinal cannabis company
Leveraging renewable energy resources in Australia
-
Manufacturing pharmaceutical-grade medicinal products
Under the European Union Good Manufacturing Practices (*EU GMP) framework
World-leading agri-pharma team with a focus on R&D
Cannaponicsis focused on cultivating medicinal cannabis under the World Health Organisation (WHO) quality framework for Good Agricultural and Collection Practices (GACP).
It is near completion of a 3,600sqm Greenhouse (pictured below) and will complete the 2,000sqm EU GM Manufacturing facility by Q2 2023, on its 165-acre freehold property in Collie WA, which will produce dried cannabis flower to be further processed into Cannaponics medicinal products.
The whole project aims to use 100% renewable resources with Cannaponics subsidiary company CannaEnergy, building a 25,000 sqm solar electrical power hydrogen micro-grid with advanced water harvesting technology.
Integrated international distribution
Fully integrated ESG for medicinal cannabis toll production and distribution to 15 domestic and international distribution channels.
The team is focused on innovative R&D from cultivation to exclusive licenses with New Age Nanotech Nano-emulsion and GATC DNA testing for personalised medicines.
The company is awaiting a pending outcome for $5m for advanced manufacturing via a Federal Government Grant.
-
Australian owned and operated
-
Eco-friendly medicinal cannabis
-
Fully licensed Office of Drug Control
-
Funded by WA State Gov $2M
-
Low cost power medicinal cannabis
-
EU GMP quality standards
-
Exclusive Licences with global partners
-
Industrial scale production
Products & Services
A renewable resource, licensed producer for medicinal cannabis cultivation, manufacturing and research.
The facility will be EU GMP compliant on our 165-acre freehold property in Collie, Western Australia.
A subsidiary company of Cannaponics, Hemponics is a food supplement and nutraceutical brand focused on providing high quality hemp-based products for the wellness and health food market.
The company Hemponics will be our catalyst for over-the-counter CBD products.
Another subsidiary wholly owned by Cannaponics, CannaEnergy will use 100% renewable resources to power the Cannaponics facility.
Leveraging advanced technology via a 25,000sqm solar power and hydrogen electrical power micro-grid coupled with water harvesting technology.
Team
- Management
- Directors
-
Eric J. Mathur
Chief Scientist
-
Willie Ooi
Chief Financial Officer
-
Warrick Hazeldine
Advisor
-
Kenneth Langford
Director of Cultivation
-
Rod Zakostelsky
Founder & Managing Director
-
Jay Stephenson
Director & Company Secretary
-
Leigh Dyson
Director
Ask us a question
Ask Us a QuestionAlready a member?
Login nowBecome a member
Register now